84 related articles for article (PubMed ID: 38580335)
1. CHK1 inhibitor induced PARylation by targeting PARG causes excessive replication and metabolic stress and overcomes chemoresistance in ovarian cancer.
Acharya G; Mani C; Sah N; Saamarthy K; Young R; Reedy MB; Sobol RW; Palle K
Cell Death Discov; 2024 Jun; 10(1):278. PubMed ID: 38862485
[TBL] [Abstract][Full Text] [Related]
2. Combining EHMT and PARP Inhibition: A Strategy to Diminish Therapy-Resistant Ovarian Cancer Tumor Growth while Stimulating Immune Activation.
Nguyen LL; Watson ZL; Ortega R; Woodruff ER; Jordan KR; Iwanaga R; Yamamoto TM; Bailey CA; To F; Jeong AD; Guntupalli SR; Behbakht K; Gibaja V; Arnoult N; Cocozaki A; Chuong EB; Bitler BG
Mol Cancer Ther; 2024 Jun; ():OF1-OF16. PubMed ID: 38863225
[TBL] [Abstract][Full Text] [Related]
3. When DNA damage responses meet tumor immunity: From mechanism to therapeutic opportunity.
Pan D; Wang Q; Shen A; Qi Z; Zheng C; Hu B
Int J Cancer; 2024 Aug; 155(3):384-399. PubMed ID: 38655783
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of STAT3: A promising approach to enhancing the efficacy of chemotherapy in medulloblastoma.
Kumar S; Arwind DA; Kumar B H; Pandey S; Nayak R; Vithalkar MP; Kumar N; Pai KSR
Transl Oncol; 2024 Aug; 46():102023. PubMed ID: 38852276
[TBL] [Abstract][Full Text] [Related]
5. PARP and PARG inhibitors in cancer treatment.
Slade D
Genes Dev; 2020 Mar; 34(5-6):360-394. PubMed ID: 32029455
[TBL] [Abstract][Full Text] [Related]
6. Poly (ADP-ribose) glycohydrolase (PARG) and its therapeutic potential.
Min W; Wang ZQ
Front Biosci (Landmark Ed); 2009 Jan; 14(5):1619-26. PubMed ID: 19273151
[TBL] [Abstract][Full Text] [Related]
7. Targeting PARG induces tumor cell growth inhibition and antitumor immune response by reducing phosphorylated STAT3 in ovarian cancer.
Martincuks A; Zhang C; Austria T; Li YJ; Huang R; Lugo Santiago N; Kohut A; Zhao Q; Borrero RM; Shen B; Cristea M; Wang EW; Song M; Rodriguez-Rodriguez L; Yu H
J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38580335
[TBL] [Abstract][Full Text] [Related]
8. PARG suppresses tumorigenesis and downregulates genes controlling angiogenesis, inflammatory response, and immune cell recruitment.
Johnson S; Karpova Y; Guo D; Ghatak A; Markov DA; Tulin AV
BMC Cancer; 2022 May; 22(1):557. PubMed ID: 35585513
[TBL] [Abstract][Full Text] [Related]
9. DNA Replication Vulnerabilities Render Ovarian Cancer Cells Sensitive to Poly(ADP-Ribose) Glycohydrolase Inhibitors.
Pillay N; Tighe A; Nelson L; Littler S; Coulson-Gilmer C; Bah N; Golder A; Bakker B; Spierings DCJ; James DI; Smith KM; Jordan AM; Morgan RD; Ogilvie DJ; Foijer F; Jackson DA; Taylor SS
Cancer Cell; 2019 Mar; 35(3):519-533.e8. PubMed ID: 30889383
[TBL] [Abstract][Full Text] [Related]
10. Selective Loss of PARG Restores PARylation and Counteracts PARP Inhibitor-Mediated Synthetic Lethality.
Gogola E; Duarte AA; de Ruiter JR; Wiegant WW; Schmid JA; de Bruijn R; James DI; Guerrero Llobet S; Vis DJ; Annunziato S; van den Broek B; Barazas M; Kersbergen A; van de Ven M; Tarsounas M; Ogilvie DJ; van Vugt M; Wessels LFA; Bartkova J; Gromova I; Andújar-Sánchez M; Bartek J; Lopes M; van Attikum H; Borst P; Jonkers J; Rottenberg S
Cancer Cell; 2018 Jun; 33(6):1078-1093.e12. PubMed ID: 29894693
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of poly(ADP-ribose) polymerase-1 or poly(ADP‑ribose) glycohydrolase individually, but not in combination, leads to improved chemotherapeutic efficacy in HeLa cells.
Feng X; Koh DW
Int J Oncol; 2013 Feb; 42(2):749-56. PubMed ID: 23254695
[TBL] [Abstract][Full Text] [Related]
12. Cancer statistics, 2023.
Siegel RL; Miller KD; Wagle NS; Jemal A
CA Cancer J Clin; 2023 Jan; 73(1):17-48. PubMed ID: 36633525
[TBL] [Abstract][Full Text] [Related]
13. STING agonism overcomes STAT3-mediated immunosuppression and adaptive resistance to PARP inhibition in ovarian cancer.
Ding L; Wang Q; Martincuks A; Kearns MJ; Jiang T; Lin Z; Cheng X; Qian C; Xie S; Kim HJ; Launonen IM; Färkkilä A; Roberts TM; Freeman GJ; Liu JF; Konstantinopoulos PA; Matulonis U; Yu H; Zhao JJ
J Immunother Cancer; 2023 Jan; 11(1):. PubMed ID: 36609487
[TBL] [Abstract][Full Text] [Related]
14. STAT proteins in cancer: orchestration of metabolism.
Li YJ; Zhang C; Martincuks A; Herrmann A; Yu H
Nat Rev Cancer; 2023 Mar; 23(3):115-134. PubMed ID: 36596870
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
